The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

NCT ID: NCT02939352

Last Updated: 2018-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High relapse rates among substance dependent individuals are likely due to a combination of factors that involve limbic circuits in the brain involved in craving, including vulnerability to salient cues. Emerging data suggests that non-invasive, targeted brain stimulation may be able to modulate activity in these circuits and decrease craving. The primary goal of this pilot study is to determine the extent to which a single session of continuous theta burst stimulation to the medial prefrontal cortex can attenuate limbic circuitry involved in craving among cocaine users and alcohol users. This will be tested through a double-blind,sham-controlled brain stimulation and brain imaging study in a cohort of polysubstance abusers and alcohol users.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This parent protocol contains two components - one of which is targeting cocaine users, the other of which is targeting heavy alcohol users (who will also serve as an appropriate control group for the cocaine users - who typically have comorbid alcohol use disorders). All participants will receive one session of real and one session of sham (randomized) continuous theta burst stimulation (TBS).TBS is a form of non-invasive transcranial magnetic stimulation (TMS).Continuous TBS is designed to lower cortical excitability, and requires a shorter stimulation period than typical low frequency TMS. The investigators will test the hypotheses that stimulation over the medial prefrontal cortex will attenuate activity in the medial prefrontal cortex (Aim 1), using single pulse TMS in the magnetic resonance imaging scanner. Through this innovative technique it is possible to apply a single pulse of TMS to the medial prefrontal cortex and model the hemodynamic response at the stimulation site as well as monosynaptic target regions, including the striatum. The investigators will also investigate the effect of TBS on neural response to drug cues (Aim 2). The results of these aims will be further correlated with self-reported assessments of craving throughout each experimental visit. These data will be preliminary data for a subsequent R01 focused on the sustained effects of multiple sessions of TBS and their efficacy in lowering craving for extended periods of time in treatment-seekers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcoholism Cocaine Addiction Drug Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cocaine Users

Participants will receive Real continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex. Participants will also receive Sham continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex.

Group Type EXPERIMENTAL

Real continuous Theta Burst Stimulation

Intervention Type DEVICE

Continuous Theta Burst stimulation delivered

Sham continuous Theta Burst Stimulation

Intervention Type DEVICE

active sham Continuous Theta Burst stimulation delivered

Alcohol Users

Participants will receive Real continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex. Participants will also receive Sham continuous Theta Burst Stimulation to the left frontal pole/medial prefrontal cortex.

Group Type EXPERIMENTAL

Real continuous Theta Burst Stimulation

Intervention Type DEVICE

Continuous Theta Burst stimulation delivered

Sham continuous Theta Burst Stimulation

Intervention Type DEVICE

active sham Continuous Theta Burst stimulation delivered

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Real continuous Theta Burst Stimulation

Continuous Theta Burst stimulation delivered

Intervention Type DEVICE

Sham continuous Theta Burst Stimulation

active sham Continuous Theta Burst stimulation delivered

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 25-55
* Non-treatment seeking cocaine users (with or without comorbid alcohol use disorder)
* Current alcohol use greater than 20 standard drinks per week
* Current DSM-V Alcohol Use Disorder diagnosis, including the loss of control item
* Currently not engaged in, and do not want treatment for, alcohol related problems
* Able to read and understand questionnaires and informed consent
* Lives within 50 miles of the study site

Exclusion Criteria

* Any current DSM-V Axis I diagnosis except Alcohol, Cocaine, or Nicotine Use Disorder
* Current or past substance dependence criteria other than cocaine, marijuana, or alcohol, smoking \>1 pack of cigarettes per day
* Current use of any psychoactive substance except cocaine, nicotine, and marijuana or medications as evidenced by self-report or urine drug screen
* Current breath alcohol concentration \>0.002
* Positive urine drug screen for stimulants (including cocaine, amphetamine, methamphetamine, etc.) at the Scanning/Stimulation visits and signs of alcohol withdrawal. Based on the sensitivity of this test, this will require that the participants abstain from cocaine use for 48 hours prior to the intervention
* History of seizures or migraine headaches
* History of head trauma or epilepsy
* Violation of other magnetic resonance imaging safety measures
* Current suicidal or homicidal ideation
* Presence of ferrous metal in the body, as evidenced by metal screening and self-report
* Severe claustrophobia or extreme obesity that preclude placement in the MRI scanner
* For female participants, pregnancy, as evidenced by a urine pregnancy test administered on the day of the scanning session
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Colleen A Hanlon, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of South Carolina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Kearney-Ramos TE, Dowdle LT, Lench DH, Mithoefer OJ, Devries WH, George MS, Anton RF, Hanlon CA. Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):599-609. doi: 10.1016/j.bpsc.2018.03.016. Epub 2018 Apr 10.

Reference Type DERIVED
PMID: 29776789 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

30506

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TDCS for Cocaine Addiction Craving
NCT03833583 COMPLETED NA
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
NCT05558358 ACTIVE_NOT_RECRUITING PHASE1/PHASE2